[Antibacterial agent Oftaquix efficacy in cataract phacoemulsification]
Related Experiment Video
Updated: May 14, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Abstract:
Clinical study is performed to estimate the efficacy of Oftaquix in cataract phacoemulsification with intraocular lens (IOL) implantation. Obtained results show that Oftaquix prescription two days before surgery allows to eliminate bacterial agents from conjunctival cavity on the day of surgery. Significant and stable antibacterial effect is demonstrated. Bacteriological study on the 19-21 day after surgery revealed bacterial growth in 6.7% of patients in experimental group and in 30% of patients in control group.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Microbiome of the Eye
Inhibitors of Bacterial DNA Synthesis
Ophthalmic Drug Delivery Systems
Hand hygiene
Hand washing...
Angle Closure Glaucoma: Treatment
